Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Who we are
We are currently looking for a Health and Safety Consultant to join our small team at Health & Safety Works.
Our team is based in East Anglia, and all consultants work from home. You may however need to travel further afield.
Deep Science Ventures (DSV), a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into commercial breakthroughs, today announced a strategic collaboration to address challenges in delivering medicines into the brain.
Oxford, UK – 3 June 2026 – PrecisionLife, a leader in AI-driven precision medicine for chronic diseases, today announced the appointments of Dr Pradip Banerjee, PhD, MBA, as an Independent Non-Executive Director and Dr Kam Pooni, PhD, as Chief Product Officer.
An exciting opportunity has arisen for a Postdoctoral Researcher to join the Whitewoods Group at the John Innes Centre, working on cutting-edge science in the field of Cell & Development Biology.
About the Whitewoods Group
LONDON, UK and VALENCIA, Spain – June 2, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Quibim and is pleased to announce the placement of Itta MacNevin as Chief Business Officer (CBO).
We have an exciting opportunity to take on a key leadership role as Facilities Manager at Mills & Reeve's Cambridge office.
The role
Xampla is seeking a Business Development and Sales Lead (Licensees, Mills and Coaters) to drive commercial growth and take full ownership of how we scale our coatings business globally.
This is about more than sales delivery: it’s about shaping our commercial strategy, building deep partnerships across the paper coatings value chain, and positioning Xampla as a trusted partner for sustainable materials innovation.
ELRIG’s Drug Discovery 2026 is back at London’s Excel, and as Europe’s leading drug discovery and life sciences conference, it will have scientific tracks covering topics including Next Generation biophysics, microbes to medicines, multiomics, AI in compound discovery and in experimental design, and bioconjugation approaches in oncology.
